ArticleCureus2026
A Rare Case of Stevens-Johnson Syndrome Secondary to Levofloxacin Administration: Presentation and Management.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stevens-Johnson syndrome (SJS) is a rare but life-threatening mucocutaneous reaction, most commonly triggered by medications and characterised by rapid progression, extensive mucosal involvement, and risk of long-term sequelae. We describe the case of a 74-year-old woman who developed severe SJS shortly after receiving levofloxacin for community-acquired pneumonia. Within days of antibiotic exposure, she experienced extensive mucocutaneous ulceration and profound ocular involvement, necessitating intensive multidisciplinary care. This case highlights the unpredictable nature of drug-associated SJS, the challenges of managing extensive ocular disease, and the importance of vigilance when prescribing widely used antibiotics. By underscoring the value of early identification and coordinated multidisciplinary care, it serves as a reminder that even familiar medications can provoke uncommon but severe reactions with the potential to cause life-changing consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.